Newsroom

Cornell patent deal helps LNC ramp-up microbiome therapeutics strategy

Dec 17, 2018

Dr. Mathieu Simon and Catherine Combot-Plétan join the Board of Directors of biotech firm LNC...

Dec 11, 2018

A Bordeaux, LNC Therapeutics veut développer l’arme absolue contre l’obésité

Oct 26, 2018

LNC Therapeutics Acquires Exclusive License for the Christensenella Patent from Cornell University

Oct 17, 2018

LNC Therapeutics acquires exclusive license for the Christensenella patent from Cornell University

Oct 15, 2018

LNC Therapeutics lance son nouvel essai clinique, OBEMINALE 2, et traite son premier patient

Oct 10, 2018